GLP-1 drugs, like semaglutide, lower risk of hospitalizations for alcohol use disorder
A long-term study suggests GLP-1 agonists, especially semaglutide, may lower the risk of alcohol use disorder hospitalizations, highlighting the potential ...
A long-term study suggests GLP-1 agonists, especially semaglutide, may lower the risk of alcohol use disorder hospitalizations, highlighting the potential ...
Despite high overall vaccination rates, unmedicated individuals with mental illness show significantly lower COVID-19 vaccine uptake, signaling the need for ...
A systematic review reveals that GLP-1 receptor agonists may help reduce certain substance use disorders, but findings are inconsistent due ...
A new study that contributes additional data to a growing body of evidence demonstrating disparities in restraint use in the ...
What question were you investigating? Despite elevated risk for substance use disorder and overdose death in the homeless population, benzodiazepine ...
In a recent study published in Molecular Psychiatry, scientists reviewed existing literature to understand how the microbiome influences neuropsychiatric disorders. ...
Contrary to expectations, the risk for relapses, overdoses and deaths related to substance use disorder didn't increase after a large-scale ...
Many of the unhoused people in Portland, Oregon, live in tents pitched on sidewalks or in aging campers parked in ...
New research from Boston Medical Center found that substance use disorders do not increase the likelihood of dying from COVID-19. ...
Nearly one in eight infants born in West Virginia between 2020 and 2022 had in-utero exposure to opioids, stimulants and/or ...
Sepoy.net is a perfect place for people who want daily updates on news related to business, technology, entertainment, health, cryptocurrency etc.
Contact: hello@sepoy.net
© 2023 Sepoy.net